Arbeitsgruppe Hodentumoren - Studien

AIO-assoziierte Studie
  zur Studie

AIO-GC-0121/ass: Reduced Intensity Radio-chemotherapy for Stage IIA/B Seminoma - SAKK 01/18
  ---in Rekrutierung---
Hodentumoren, Rezidivsituation

AIO-assoziierte Studie
www.clinicltrials.gov zur Studie

AIO-GC-0416/ass: A Randomized phase III trial comparing conventional-dose chemotherapy using paclitaxel, ifosfamide, and cisplatin (TIP) with high dose chemotherapy using mobilizing paclitaxel followed by High-dose carboplatin and etoposide (TI-CE) as first salvage treatment in relapsed or refractory germ cell tumours
  ---in Rekrutierung---
LETZTE AKTUALISIERUNG DIESER SEITE AM: 10.03.2021